MRM vs. CHGG, YSXT, HCMA, NAMI, KIDZ, KUKE, BEDU, FEDU, AZI, and ZCMD
Should you be buying MEDIROM Healthcare Technologies stock or one of its competitors? The main competitors of MEDIROM Healthcare Technologies include Chegg (CHGG), YSX Tech (YSXT), HCM Acquisition (HCMA), NAMI (NAMI), Classover (KIDZ), Kuke Music (KUKE), Bright Scholar Education (BEDU), Four Seasons Education (Cayman) (FEDU), Autozi Internet Technology (Global) (AZI), and Zhongchao (ZCMD). These companies are all part of the "personal services" industry.
MEDIROM Healthcare Technologies vs. Its Competitors
MEDIROM Healthcare Technologies (NYSE:MRM) and Chegg (NYSE:CHGG) are both small-cap personal services companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.
95.2% of Chegg shares are owned by institutional investors. 40.2% of MEDIROM Healthcare Technologies shares are owned by insiders. Comparatively, 3.7% of Chegg shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
MEDIROM Healthcare Technologies has a net margin of 0.00% compared to Chegg's net margin of -151.10%. MEDIROM Healthcare Technologies' return on equity of 0.00% beat Chegg's return on equity.
Chegg has a consensus target price of $1.70, suggesting a potential upside of 13.71%. Given Chegg's higher possible upside, analysts clearly believe Chegg is more favorable than MEDIROM Healthcare Technologies.
MEDIROM Healthcare Technologies has higher revenue and earnings than Chegg.
In the previous week, Chegg had 1 more articles in the media than MEDIROM Healthcare Technologies. MarketBeat recorded 2 mentions for Chegg and 1 mentions for MEDIROM Healthcare Technologies. MEDIROM Healthcare Technologies' average media sentiment score of 0.71 beat Chegg's score of 0.28 indicating that MEDIROM Healthcare Technologies is being referred to more favorably in the media.
MEDIROM Healthcare Technologies has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Chegg has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500.
Summary
MEDIROM Healthcare Technologies beats Chegg on 9 of the 14 factors compared between the two stocks.
Get MEDIROM Healthcare Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for MRM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MEDIROM Healthcare Technologies Competitors List
Related Companies and Tools
This page (NYSE:MRM) was last updated on 7/25/2025 by MarketBeat.com Staff
Free MRM Stock Alerts